Abstract
AbstractWith innovation becoming more collaborative, the influence of digital business strategy (DBS) on interfirm cooperation has grown. This study investigates how DBS can enhance collaboration innovation capabilities across pharmaceutical companies in developing countries. Further, it investigates organizational culture as a moderating variable in the relationship between DBS and collaborative innovation capability (CIC). A total of 205 questionnaire responses were gathered on six Jordanian pharmaceutical corporations. The findings showed that each DBS element (development, objectives, resources, management capabilities, and digital leadership) positively affected CIC, and that organizational culture positively moderated the relationship between DBS and CIC. These results provide valuable insights for managers seeking to improve collaborative capability by leveraging digital business strategies and organizational culture.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
